Cargando…
Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results
OBJECTIVE: The objective of this systematic review is to summarize the effects of ivermectin for the prevention and treatment of patients with COVID-19 and to assess inconsistencies in results from individual studies with focus on risk of bias due to methodological limitations. METHODS: We searched...
Autores principales: | Izcovich, Ariel, Peiris, Sasha, Ragusa, Martín, Tortosa, Fernando, Rada, Gabriel, Aldighieri, Sylvain, Reveiz, Ludovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684188/ https://www.ncbi.nlm.nih.gov/pubmed/34933115 http://dx.doi.org/10.1016/j.jclinepi.2021.12.018 |
Ejemplares similares
-
Challenges to delivering evidence-based management for long COVID
por: Peiris, Sasha, et al.
Publicado: (2023) -
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
por: Hill, Andrew, et al.
Publicado: (2022) -
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud
por: Hill, Andrew, et al.
Publicado: (2022) -
An opportunity for evidence-based care of individuals with monkeypox
por: Donato, Manuel, et al.
Publicado: (2023) -
Ivermectin and malaria control
por: Ōmura, Satoshi, et al.
Publicado: (2017)